Klaria Pharma Holding AB (publ.) Balance Sheet Health
Financial Health criteria checks 6/6
Klaria Pharma Holding AB (publ.) has a total shareholder equity of SEK29.2M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK69.0M and SEK39.8M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr937.00k |
Equity | kr29.22m |
Total liabilities | kr39.79m |
Total assets | kr69.01m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6FN's short term assets (SEK69.0M) exceed its short term liabilities (SEK39.8M).
Long Term Liabilities: 6FN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 6FN is debt free.
Reducing Debt: 6FN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 6FN has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 6FN is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 16.1% per year.